BioVie Inc.
NASDAQ: BIVI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Cuong Viet Do
- Employees
- 14
- Headquarters
- Carson City, United States
- IPO year
- 2020
- Market cap
- $14.5M
- Website
- https://bioviepharma.com
Loading BIVI…
Loading profile data…Frequently asked questions about BIVI
What does BioVie Inc. (BIVI) do?
BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resultin...
Where does BIVI trade?
BioVie Inc. (BIVI) trades on the NASDAQ Capital Market.
What sector is BIVI in?
BioVie Inc. (BIVI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BioVie Inc.?
Cuong Viet Do is the chief executive officer of BioVie Inc. (BIVI).
Where is BioVie Inc. headquartered?
BioVie Inc. is headquartered in United States.
Does BIVI pay a dividend?
BioVie Inc. (BIVI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIVI go public?
BioVie Inc. (BIVI) completed its initial public offering in 2020.